Results 81 to 90 of about 128,840 (306)

Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?

, 2020
PURPOSE OF REVIEW: This review explores the concepts of monogenic and the so-called polygenic familial hypercholesterolemia and how the identification of familial hypercholesterolemia as a monogenic condition and its separation from polygenic primary ...
Ray, Kausik K, Brandts, Julia, Dharmayat, K. I., Ray, K. K., Vallejo Vaz, Antonio Javier, Vallejo-Vaz, Antonio J, Brandts, J., Dharmayat, Kanika I   +7 more
core   +1 more source

THE REDUCTION OF CHOLESTEROL WITH CUPPING THERAPY ON CHOLESTEROL REDUCTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA

Jurnal Ners, 2017
Introduction: Hypercholesterolemia is a risk factor causes of death at younger ages. Hypercholesterolemia may increase the risk of atherosclerosis, coronary heart disease, pancreatitis (pancreas inflammation in organs), diabetes mellitus, thyroid ...
Zahid Fikri, Nursalam Nursalam, Eka Mishbahatul Mar'ah Has   +2 more
doaj   +1 more source

Molecular basis of familial hypercholesterolemia

, 2017
Purpose of review To provide an overview about the molecular basis of familial hypercholesterolemia. Recent findings Familial hypercholesterolemia is a common hereditary cause of premature coronary heart disease. It has been estimated that 1 in every 250
Hovingh, Gerard K., Gerard K. Hovingh, Caroline S. Bruikman, Bruikman, Caroline S., John J.P. Kastelein, Kastelein, John J. P.   +5 more
core   +1 more source

Artificial Intelligence in Colonoscopy Surveillance for Lynch Syndrome: Emerging Evidence, Lessons Learned From Average‐Risk Populations, and Future Directions

International Journal of Cancer, EarlyView.
ABSTRACT Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome and is characterized by an accelerated adenoma‐carcinoma sequence, a relatively higher prevalence of flat and subtle CRC precursor lesions, and exceptionally high adenoma miss rates despite intensive colonoscopy surveillance.
Robert Hüneburg, Querijn N. E. van Bokhorst, Evelien Dekker, Jacob Nattermann   +3 more
wiley   +1 more source

Healthcare activities before familial hypercholesterolemia diagnosis: a nationwide register-based study in Denmark

BMC Primary Care
Background Familial hypercholesterolemia is a common yet underdiagnosed genetic disorder that significantly increases the risk of premature atherosclerotic cardiovascular disease.
Simon Graff, Kirsten Høj, Bo Christensen, Flemming Bro, Helle Lynge Kanstrup, Henrik Schou Pedersen   +5 more
doaj   +1 more source

Asymptomatic Cardiotoxicity After High‐Dose Anthracycline Treatment in Sarcoma Patients Assessed by Biomarkers and Echocardiography

International Journal of Cancer, EarlyView.
ABSTRACT Treatment of sarcoma includes high‐dose anthracyclines, which can cause cardiotoxicity. This study assesses the correlation of cardiac biomarkers and echocardiographic parameters on asymptomatic cardiotoxicity in sarcoma patients treated with anthracyclines.
Elissa A. S. Polomski, Frank M. Speetjens, J. Wouter Jukema, Julius C. Heemelaar, Michiel A. J. van de Sande, Hans Gelderblom, M. Louisa Antoni   +6 more
wiley   +1 more source

Association between height and hypercholesterolemia in adults: a nationwide population-based study in Korea

Lipids in Health and Disease, 2019
Background Previous studies reported that stature is inversely related to the risk of cardiovascular disease. However, there is limited evidence on the association between height and lipid profiles.
Mi Yeon Lee, Ga Eun Nam, Kyungdo Han, Da Hye Kim, Yang Hyun Kim, Kyung Hwan Cho, Yong Gyu Park   +6 more
doaj   +1 more source

QT interval prolongation noted in one percent of 2553 Asian patients with schizophrenia: Findings from the REAP‐AP survey

Kaohsiung Journal of Medical Sciences, 2020
Although the association between antipsychotic use and corrected QT interval (QTc) prolongation has been repeatedly confirmed, the relationship has been rarely studied in a practical setting.
Seon‐Cheol Park, Bong Ju Lee, Jae Hong Park, Hiroaki Kawasaki, Ajit Avasthi, Sandeep Grover, Andi J. Tanra, Shih‐Ku Lin, Afzal Javed, Chay Hoon Tan, Norman Sartorius, Naotaka Shinfuku, Yong Chon Park   +12 more
doaj   +1 more source

Antibody-Based Therapeutics for Hypercholesterolemia [PDF]

Brian Tomlinson,1 Paul Chan2 1Faculty of Medicine, Macau University of Science & Technology, Macau, 999078, People’s Republic of China; 2Division of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei ...
Tomlinson B, Chan P
core  

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia

, 2010
Jun SasakiPharmaceutical Medicine, International University of Health and Welfare Graduate School, Fukuoka, JapanAbstract: Pitavastatin was first developed in Japan and is expanding the regions in which it is clinically available.
Jun Sasaki
core   +1 more source